Difference between revisions of "Adopt Universal Screening for Pregnant People"

From SAFE Solutions
Jump to navigation Jump to search
user>Dmt7109
user>Dmt7109
Line 1: Line 1:
<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]


Line 69: Line 69:
[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]
[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]
<div class="mw-parser-output">
<div class="mw-parser-output">
= Scorecard Building =
= &nbsp; =
 
Potential Objective Details(Under construction)&nbsp;<br/> Potential Measures and Data Sources(Under construction)&nbsp;<br/> Potential Actions and Partners(Under construction)&nbsp;
</div>  
</div>  
= Resources to Investigate =
[[RTI_-_Adopt_Universal_Screening_for_Pregnant_Women|More RTI on Adopt Universal Screening for Pregnant Women]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span>
{| class="wiki_table"
{| class="wiki_table"
|-
|-
Line 94: Line 88:
#[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]  
#[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]  
#[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]  
#[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]  
</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>  
</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>  
[[Category:SAFE-Full Spectrum Prevention]]
[[Category:SAFE-Full Spectrum Prevention]]

Revision as of 12:18, 15 March 2020

Return to  ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use


Another potential strategy is to universally screen all pregnant women for substance abuse. In Kaiser Permanente's Early Start program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.[1]

Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women - Kaiser Permanente
Overview of program:

  • Universally screen all pregnant women
  • No mandated reporting for toxicology
  • Mental health provider apart of obstetric care
  • Use video conferencing and telephone to provide care to immediate and remote care

Outcome Successes:

  • Show decrease in morbidity for mothers and babies
  • Cost beneficial
  • Reduces all barriers to care, including in prenatal care


The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS
Method:

  • SBIRT -- Screening, Brief Intervention, and Referral to Treatment --> Figure 2: SBIRT Flow Chart
 
  • Components of Interview: raise subject, provide feedback, enhance motivation, negotiate plan
  • Purpose of screening for substance abuse is to stratify women into zones of risk given their pattern of use --> Use "risk pyramid" seen in Figure 1.

Screening Instruments:
  • CAGE -- Cut down, Annoyed, Guilt, Eye opener
  • T-ACE -- Takes, Annoyed, Cut down, Eye opener
  • TWEAK -- Tolerance, Worry, Eye opener, Amnesia, Cut down
  • 4Ps -- Past, Present, Parents, Partner
  • NIDA Quick Screen -- Uses 3 open-ended questions regarding alcohol, tobacco, and other drugs

Key Screening Conclusions:

  • Screening should be done for all pregnant women and throughout pregnancy for those at risk
  • Screening can be done by a provider using a validated instrument during follow-up or by asking standardized questions during interview
  • Screening must be nonjudgemental and open-ended
  • Urine toxicology should not be used in place of screening

 

Promising Practices for Standardized Screening

Indiana State Department of Health

In 2014, because of the high rate of opioid prescriptions, the Indiana General Assembly charged the Indiana State Department of Health (ISDH) to: develop a standard clinical definition of NAS and a standardized process of identifying it, identify the resources hospitals need to do this, and then establish a voluntary pilot program with hospitals to implement this standardized NAS identification. As of 2016, 26 of 89 Indiana Birthing Hospitals are taking part in this pilot screening program

  To understand and address perinatal substance use, accurate data needed to be collected through standardized screening and testing:

 

  • When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.
  • Any woman with a positive verbal screen at any point during pregnancy, including at presentation for delivery, is requested to consent to a urine toxicology screening.
  • Babies whose mothers had a positive verbal screen or toxicology screen, or babies whose mothers did not consent to the toxicology screen will be tested for evidence of maternal substance use using the infant’s umbilical cord.
    • Note: Umbilical cord testing, not meconium stool, was used on all infants.
  • Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.


ISDH noted that universal screening in a non-punitive environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.[2]

See Improve Identifying and Data Collecting on NAS for more information on defining, testing, and reporting data about NAS.
 

Tools & Resources

TR - Adopt Universal Screening for Pregnant Women

 

Reviewer Date Comments
     

Sources


  1. [1]
  2. [2]